RIVERLAND MEDICAL CENTER — History
CCN 191318 | 3-year financial timeline | COVID resilience: 78/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
+29.1%
Revenue CAGR (3yr)
-8.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $20M | $25M | +22.6% | +29.1% |
| Operating Expenses | $18M | $25M | $27M | +8.4% | +22.5% |
| Operating Margin | -20.9% | -23.2% | -8.9% | +61.8% | +0.0% |
| Net Income | $-3M | $-5M | $-2M | +53.1% | +0.0% |
| Licensed Beds | 25 | 25 | 23 | -8.0% | -4.1% |
| Total Patient Days | 3,778 | 4,554 | 4,462 | -2.0% | +8.7% |
| Medicare Day % | 79% | 68% | 65% | -4.1% | -9.2% |
| Medicaid Day % | 3% | 3% | 2% | -20.5% | -19.5% |
COVID Impact & Recovery
Resilience Score: 78/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +66.8% ($15M → $25M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+29.1%
This Hospital
+7.6%
State Avg
Latest Margin
-8.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $30M | -2.8% |
| FY2024 (proj) | $35M | 3.2% |
| FY2025 (proj) | $39M | 9.2% |